EE200300064A - Farmatseutiline kompositsioon C. pneumoniae pooltpõhjustatud infektsioonide raviks ja/või ennetamiseks, mahekompositsioon ja nende kasutamine - Google Patents

Farmatseutiline kompositsioon C. pneumoniae pooltpõhjustatud infektsioonide raviks ja/või ennetamiseks, mahekompositsioon ja nende kasutamine

Info

Publication number
EE200300064A
EE200300064A EEP200300064A EEP200300064A EE200300064A EE 200300064 A EE200300064 A EE 200300064A EE P200300064 A EEP200300064 A EE P200300064A EE P200300064 A EEP200300064 A EE P200300064A EE 200300064 A EE200300064 A EE 200300064A
Authority
EE
Estonia
Prior art keywords
prevention
treatment
composition
pharmaceutical composition
pneumoniae infections
Prior art date
Application number
EEP200300064A
Other languages
English (en)
Estonian (et)
Inventor
Vuorela Heikki
Vuorela Pia
Hiltunen Raimo
Leinonen Maija
Saikku Pekka
Original Assignee
Control-Ox Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FI20001832A external-priority patent/FI113942B/fi
Application filed by Control-Ox Oy filed Critical Control-Ox Oy
Publication of EE200300064A publication Critical patent/EE200300064A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP200300064A 2000-08-17 2001-08-16 Farmatseutiline kompositsioon C. pneumoniae pooltpõhjustatud infektsioonide raviks ja/või ennetamiseks, mahekompositsioon ja nende kasutamine EE200300064A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22573500P 2000-08-17 2000-08-17
FI20001832A FI113942B (fi) 2000-08-18 2000-08-18 Kasviperäisten fenolisten yhdisteiden käyttö valmistettaessa klamydiainfektion hoidossa ja ennaltaehkäisyssä käyttökelpoista farmaseuttista valmistetta, terveyteen myönteisesti vaikuttavaa ravintoainekoostumusta tai koostumusta lisättäväksi tällaisiin elintarvikkeisiin
PCT/FI2001/000726 WO2002014464A2 (en) 2000-08-17 2001-08-16 Plant-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections

Publications (1)

Publication Number Publication Date
EE200300064A true EE200300064A (et) 2004-12-15

Family

ID=26161043

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300064A EE200300064A (et) 2000-08-17 2001-08-16 Farmatseutiline kompositsioon C. pneumoniae pooltpõhjustatud infektsioonide raviks ja/või ennetamiseks, mahekompositsioon ja nende kasutamine

Country Status (21)

Country Link
EP (1) EP1309333B1 (xx)
JP (1) JP2004506656A (xx)
KR (1) KR100851357B1 (xx)
CN (1) CN100500141C (xx)
AR (1) AR034141A1 (xx)
AT (1) ATE441424T1 (xx)
AU (2) AU8220101A (xx)
BR (1) BR0113463A (xx)
CA (1) CA2419716A1 (xx)
CZ (1) CZ2003449A3 (xx)
DE (1) DE60139783D1 (xx)
EE (1) EE200300064A (xx)
ES (1) ES2330306T3 (xx)
HU (1) HUP0300732A3 (xx)
MX (1) MXPA03001435A (xx)
NO (1) NO20030728L (xx)
NZ (1) NZ524128A (xx)
PT (1) PT1309333E (xx)
SG (1) SG90259A1 (xx)
TW (1) TWI282275B (xx)
WO (1) WO2002014464A2 (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4571829B2 (ja) * 2003-07-15 2010-10-27 林原 健 抗クラミジア組成物
CA2610211C (en) 2005-05-30 2012-02-21 Hyeong Kyu Lee Pharmaceutical composition comprising an extract of pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity
US8455541B2 (en) 2005-05-30 2013-06-04 Korea Research Institute Of Bioscience And Biotechnology Pharmaceutical composition comprising an extract of pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity
FR2890311B1 (fr) * 2005-09-07 2009-10-30 Oreal Utilisation cosmetique d'un extrait vegetal du genre rosa comme agent empechant ou reduisant l'adhesion des microorganismes sur la surface de la peau et/ou des muqueuses
WO2009003832A2 (en) * 2007-07-05 2009-01-08 Unilever N.V. Composition comprising polyphenol
WO2009003838A2 (en) * 2007-07-05 2009-01-08 Unilever N.V. Composition comprising polyphenol
US9028890B2 (en) 2010-06-25 2015-05-12 Horphag Research (Ip) Pre Ltd. Composition for improving sexual wellness
CN102935131B (zh) * 2011-08-15 2015-01-07 天津药物研究院 枳实总黄酮提取物在制备用于治疗哮喘药物中的应用
KR101419706B1 (ko) * 2012-12-28 2014-07-15 한국식품연구원 생체내에서의 항염증 효능이 증가된 염증치료용 루테올린 혼합 조성물을 제조하는 방법 및 항염증이 증가된 염증치료용 루테올린 혼합 조성물
KR102105532B1 (ko) * 2013-10-17 2020-04-29 (주)아모레퍼시픽 만능 줄기세포의 유도 방법 및 상기 방법에 의해 제조된 만능줄기세포
MX2017007829A (es) * 2014-12-23 2017-10-02 Neem Biotech Ltd Composicion antimicrobiana.
US10039727B2 (en) * 2015-04-21 2018-08-07 Commissariat A L'energie Atomique Et Aux Energies Alternatives Adamantane or pinene derivatives for use in the treatment of chlamydiales infections
IT201700089680A1 (it) * 2017-08-03 2019-02-03 Giuliani Spa Composizione sinergica come promoter di autofagia/a synergistic composition as a promoter of autophagy
KR102166099B1 (ko) 2018-08-01 2020-10-15 건국대학교 산학협력단 비아칸젤리신을 포함하는 폐 또는 뇌의 생체분포도 증진을 위한 약제학적 제형
KR102313068B1 (ko) 2018-08-01 2021-10-14 건국대학교 산학협력단 비아칸젤리신을 포함하는 폐 또는 뇌의 생체분포도 증진을 위한 약제학적 제형
CN111675220B (zh) * 2020-05-08 2023-06-27 江西江氨科技有限公司 碳酸酯生产尾气中含co2提取精制系统
CN113024575B (zh) * 2021-03-23 2022-04-22 上海市奉贤区中心医院 一种黄烷-3-醇并苯丙素杂合物、其制备方法及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE793411Q (en) * 1970-01-31 1973-04-16 Magyar Hutoipar Edible base for soups,vegetables and sauces - with an onion flavour
DE3206725A1 (de) 1981-05-13 1982-12-02 Merck Patent Gmbh, 6100 Darmstadt Schwer loesliche salze von aminoglykosidantibiotika
EP0348509B1 (en) * 1987-12-10 1993-03-24 TSUMURA & CO. Anti-retroviral drug
DE3805685A1 (de) * 1988-02-24 1989-09-07 Gruenenthal Gmbh Antipsoriatikum
US4891221A (en) 1988-11-23 1990-01-02 Edward Shanborm Whole blood antiviral process and composition
EP0496230A1 (de) * 1991-01-23 1992-07-29 ASTA Medica Aktiengesellschaft Herstellung eines Kamillenextraktes mit antimikrobiellen Eigenschaften
CN1106682A (zh) * 1994-02-05 1995-08-16 蔡惠明 一种用于治疗妇女阴道炎及常见性病预防的中药制剂
US5474774A (en) * 1994-03-25 1995-12-12 Jlb, Inc. Adhesion inhibiting composition
CN1151846A (zh) * 1995-12-15 1997-06-18 四川保宁制药厂 银杏保健饮料
EP0948965B1 (en) * 1997-07-11 2004-06-02 Toray Industries, Inc. Stable medicinal compositions containing 4,5-epoxymorphinane derivatives
DK1014969T3 (da) * 1997-09-09 2009-03-16 Univ Rutgers Plante-proanthocyanidin-ekstrakt, der er effektiv til inhibering af adhærens af bakterier med P-type fimbriae til overflader
EP1043318A4 (en) * 1997-11-19 2001-02-07 Tets Viktor Veniaminovich SALTS OF 5,5'-ARYLIDENEBISBARBITURIC ACIDS AND 5,5'-ARYLIDENEBIS (2-THIOBARBITURIC) AND 5.5'-ARYLIDENEBIS (2-THIOBARBITURIC ACIDS) HAVING ANTIBACTERIAL, ANTI-CHLAMYDIOSE AND ANTIVIRULAR ACTION
DE69918781T2 (de) * 1998-04-21 2005-06-30 Mitsui Norin Co., Ltd. Die verwendung von tee-polyphenolen zur herstellung von anti-chlamydia mitteln
CN1226405A (zh) * 1998-12-17 1999-08-25 童忠良 银杏沙棘饮料

Also Published As

Publication number Publication date
WO2002014464A2 (en) 2002-02-21
JP2004506656A (ja) 2004-03-04
MXPA03001435A (es) 2004-12-13
PT1309333E (pt) 2009-09-29
HUP0300732A2 (hu) 2003-09-29
BR0113463A (pt) 2003-07-15
AR034141A1 (es) 2004-02-04
KR100851357B1 (ko) 2008-08-08
DE60139783D1 (de) 2009-10-15
CZ2003449A3 (cs) 2003-06-18
NO20030728D0 (no) 2003-02-14
NO20030728L (no) 2003-04-14
CN100500141C (zh) 2009-06-17
WO2002014464B1 (en) 2002-11-21
EP1309333B1 (en) 2009-09-02
SG90259A1 (en) 2002-07-23
WO2002014464A3 (en) 2002-05-10
ES2330306T3 (es) 2009-12-09
AU2001282201B2 (en) 2006-05-11
HUP0300732A3 (en) 2005-09-28
CA2419716A1 (en) 2002-02-21
ATE441424T1 (de) 2009-09-15
TWI282275B (en) 2007-06-11
EP1309333A2 (en) 2003-05-14
AU8220101A (en) 2002-02-25
CN1454093A (zh) 2003-11-05
KR20030051623A (ko) 2003-06-25
NZ524128A (en) 2006-01-27

Similar Documents

Publication Publication Date Title
EE200300064A (et) Farmatseutiline kompositsioon C. pneumoniae pooltpõhjustatud infektsioonide raviks ja/või ennetamiseks, mahekompositsioon ja nende kasutamine
CL2004001174A1 (es) Composicion farmaceutica que comprende: 1-(4-fluorofenil)-3(r)-[3-(4-fluorofenil)-3(s)-hidroxipropil]-4(s)-(4-hidroxifenil)-2-acetidinona (ezetimiba) y excipientes; y su uso en el tratamiento y/o prevencion de aterosclerosis, hipercolesterolemia, dia
EE200000468A (et) Ühendid, nende kasutamine ja farmatseutiline kompositsioon
PT1313489E (pt) Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet
SE0102315D0 (sv) Compounds
EE05475B1 (et) Superantigeeni sisaldav konjugaat, konjugaadi kasutamine ja konjugaati sisaldav farmatseutiline kompositsioon
CL2004000930A1 (es) Compuesto derivado de dihidroquinazolina de formula definida, util para el tratamiento y/o profilaxis de infecciones virales; composicion farmaceutica que comprende al compuesto y uso del compuesto en la preparacion de medicamentos.
EE200100391A (et) Peptidüül-heterotsüklilised ketoonid, nende kasutamine ja farmatseutiline kompositsioon
ITTO20010005A1 (it) Formulazione farmaceutica.
ATE291438T1 (de) Pharmazeutische zusammensetzung zur behandlung von akutem schmerz, chronischem schmerz und/oder neuropathischem schmerz und migräne
EE05183B1 (et) Asabitsklilised hendid, nende valmistamine ja kasutamine ravimitena ning neid sisaldav farmatseutiline kompositsioon
EE200200487A (et) Asetidiini derivaadid, nende valmistamismeetodid ja farmatseutiline kompositsioon
EE200300212A (et) Ravimite kombinatsioonid (näiteks kloorpromasiin ja pentamidiin) neoplastiliste haiguste raviks
EE200300311A (et) Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim
ATE491436T1 (de) Zusammensetzungen gegen infektionen zur behandlung erkrankten gewebes wie z.b. fieberbläschen
EE200100684A (et) Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE200300327A (et) Uurea derivaadid, nende valmistamismeetodid, kasutamine ja farmatseutiline kompositsioon
NO20042739L (no) Farmasoytiske sammensetninger av 5,6,14-triazatetracyklo(10.3.1.0(2,11).0(4,9))-heksadeca-2(11)3,5,7,9-pentan
DE60041753D1 (de) Arzneimittel zur behandlung von c. pneumoniae infektionen
CL2007003332A1 (es) Compuestos derivados de heterociclos condensados; compuestos intermediarios; composicion farmaceutica; y uso en la prevencion o tratamiento de infecciones bacterianas.
EE200300193A (et) Asendatud bensimidasoolid, nende kasutamine ja ravim
EE05020B1 (et) Glburiidi ravimkoostis
CL2003001415A1 (es) Compuestos d derivados de naftil, quinolinil e isoquinolinil urea; composicion farmaceutica; y uso en el tratamiento y prevencion de condiciones de dolor y en el sibndrome del colon irritable y condiciones asociadas.
EE200200342A (et) Asendatud 8-arüülkinoliinid, nende kasutamine, farmatseutiline kompositsioon ja prekursorühend
NO20040726L (no) Kombinasjonspreparater av arylsubstituerte propanolaminderivater med andre aktive forbindelser og anvendelse derav.